Physician

Jason H Brajer, M.D.

According to 2025 Medicare claims, Jason Brajer, M.D. (NPI: 1609856723) practices anesthesiology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is JB PAIN FREE MD PLLC (NPI: 1316441017; TIN: 823510712) and primary practice location at 17356-2605.

Brajer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 293 traditional Medicare patients, billed 5,862 HCPCS/CPT codes, and received $663,015 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 205 prescription claims across 80 beneficiaries totaling $46,907 in drug costs, led by Tizanidine Hcl (Tizanidine Hcl). Open Payments data shows 52 records totaling $998. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $157,145 to $663,015. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $53,675 and ending at $46,907. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	171	2,132	$157,145
2016	183	2,674	$191,677
2017	160	2,238	$170,190
2018	126	1,448	$114,287
2019	127	963	$46,551
2020	372	3,678	$157,077
2021	134	3,277	$178,331
2022	99	943	$135,379
2023	344	8,617	$658,233
2024	293	5,862	$663,015

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	177	1,258	$53,675
2016	176	1,379	$56,753
2017	176	1,463	$86,628
2018	134	794	$39,513
2019	250	1,080	$46,666
2020	283	1,848	$67,267
2021	48	105	$2,672
2022	27	64	$10,616
2023	78	169	$56,938
2024	80	205	$46,907

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	261	1,340	$235
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	127	196	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	266	1,695	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	148	313	$66
98977	Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days	104	425	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tizanidine Hcl	Tizanidine Hcl	78	2,271	$646
Gabapentin	Gabapentin	23	672	$489
Meloxicam	Meloxicam	19	616	$58
Prednisone	Prednisone	11	80	$15

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$998	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason H. Brajer, M.D.?

Tedicare shows public-source Medicare data for Jason H. Brajer, M.D. (NPI 1609856723), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason H. Brajer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jason H. Brajer, M.D.?

Jason H. Brajer, M.D. is linked to JB PAIN FREE MD PLLC (billing NPI 1316441017) in the available physician profile data.

Does Jason H. Brajer, M.D. have Open Payments data?

Jason H. Brajer, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.